Treatment

AVIHepC1 clinical trials

1 indexed studies · 1 currently recruiting

Not yet recruitingPHASE1
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
This study is testing a new vaccine to prevent Hepatitis C. We want to see if it's safe and if it helps your body make "germ fighters" against the virus. It's for healthy adults aged 18-45.
For: Hepatitis C
Canada